A recent study from the RAND Corporation, one of the country’s most trusted analytic organizations, finds a current shortage of 3,800 anesthesiologists and 1,282 nurse anesthetists. However, if current trends continue, a dramatic shortage of anesthesiologists and a significant surplus of nurse anesthetists are projected by 2020.
The Center for Integration of Medicine and Innovative Technology (CIMIT®) and Induct Software™ AS (Induct), “The Open Innovation Company™,” today announced a long-term strategic alliance under which they will work together to implement a Web-based innovation management system based upon the successful CIMIT Model. The collaboration will draw on the strengths of each organization to develop Web-based tools that support the accelerated implementation of leading-edge ideas, clinical systems and medical devices through multidisciplinary teams of innovators.
The Cedars-Sinai Heart Institute has opened an innovative 30-bed in-patient unit dedicated to providing advanced heart failure patients with an intensive, multidisciplinary approach to inpatient care.
For one year and counting, Long Island Jewish (LIJ) Medical Center has achieved a zero central-line infection rate in its surgical intensive care unit (SICU), a significant accomplishment for hospitals.
Confidential cancer screenings will include blood tests and exams by a Loyola urologist.
Looking to gain further understanding about the impact of cancer on patients and families, New Jersey’s only NCI-Comprehensive Cancer Center is expanding its behavioral science focus by welcoming nationally-recognized population science researcher Sharon Manne, PhD, who is the recipient of major NIH grant awards.
Residents at Courtland Gardens Nursing & Rehabilitation Center in Randallstown, MD, are using one of their favorite hobbies to improve the environment. The residents are taking part in programs where they plant flowers using compost from their own cafeteria and others.
Sub-millimeter accuracy and real-time patient imaging, positioning, beam shaping, including many other data points, help make TrueBeam a leading-edge radiation treatment system. UAB's Hazelrig-Salter Radiation Oncology Center is the third U.S. site to acquire the technology.
The University of Michigan Medical School has hired 184 new faculty members since May, boosting the total Medical School faculty to 2,254 — its highest point ever.
Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.
Russell Harris, MD, MPH, professor of medicine at UNC and a member of UNC Lineberger Comprehensive Cancer Center, wrote an editorial in the Journal of the National Cancer Institute about a study concluding that CTC or “virtual” colonoscopy is not cost effective compared with colonoscopy if reimbursed at the same rate as colonoscopy.
NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.
Cancer patients at the Marjorie G. Weinberg Cancer Center, located on the Gottlieb Memorial Hospital campus, are now being seen by Loyola University Health System physicians.
The Methodist DeBakey Heart & Vascular Center today opened the country’s most advanced hybrid, robotic operating room. The new suite integrates advanced robotics, imaging and navigation with surgery to offer patients the least invasive and safest surgical and interventional treatments for cardiovascular disease.
Cedars-Sinai Medical Center has received its third consecutive full accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP), whose goal is to ensure that research institutions meet the highest standards in respecting and protecting individuals who participate in research. This is done through a rigorous review process that accredits only those organizations that rigorously demonstrate tangible evidence—through policies, procedures, and practices—of their commitment to scientifically and ethically safe and sound research, and to continuous improvement.
A new system that utilizes a precise a GPS-like system to track prostate cancer tumors is now being offered to patients undergoing radiation therapy at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute. The monitoring system, called Calypso, allows radiation beams to more precisely target the cancer as it gives real-time positioning information that allows the radiation beams to focus directly on the cancer.
AHRQ's annual release of state-by-state data on health care quality now includes new data on health insurance categorized by source of payment.
Physicians in three Northern Ontario communities are now virtually linked at all times to pathology specialists at University Health Network (UHN), thanks to a revolutionary new way of diagnosing pathology cases over the Internet.
A portable heart/lung machine helps move critically ill patients easily and safely to different areas of the hospital for medical tests or from outlying hospitals to the medical center for specialized treatment.
Johns Hopkins Medicine (JHM) and All Children’s Hospital & Health System (ACH) of St. Petersburg, Fla., have signed a letter of intent to integrate. After appropriate due diligence is completed sometime later this year, ACH will join the Johns Hopkins Health System (JHHS) as a fully integrated member of JHM.
Vanderbilt University Medical Center and affiliated VA Tennessee Valley Healthcare System are the first in the U.S. to perform a specialized PET/CT scan to successfully locate the presence of tumors.
Researchers from the La Jolla Institute for Allergy & Immunology have joined forces with the Dana-Farber Cancer Institute in Boston and Washington University in St. Louis to investigate a potential new therapy for sickle cell disease, a severe and chronic illness affecting more than 70,000 Americans and several million people worldwide. A drug called Lexiscan™ (regadenoson - Astellas Pharma US,Inc.), approved by the Food and Drug Administration as a pharmacologic stress agent used to diagnose heart disease in some patients, will be tested in the multi-center clinical trial. Patient recruitment for the trial is under way.
Levindale Hebrew Geriatric Center and Hospital in Baltimore, Maryland, has officially opened its expanded Behavioral Health Unit. Doubling its capacity from 20 to 40 beds, the unit provides comprehensive care for geriatric patients who have both medical and behavioral health challenges that require 24-hour supervision.
The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with cancer of the oropharynx (back of the mouth)) to participate in a Phase I clinical trial.
The University of Texas Health Science Center at Houston (UTHealth) has reached an agreement with other institutions that will allow it to take the next step in commercially developing an innovative medical imaging system that uses night vision technology to tackle a common side effect of cancer treatment.
The Endocrine Society, American Diabetes Association and American Association of Clinical Endocrinologists issue joint statement in response to an FDA panel’s recommendation to keep rosiglitazone (Avandia) on the market
A new study being published in the journal Urology shows that Proantinox®, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat®, and now available directly to consumers as new Cystex® Liquid Cranberry Complex with Proantinox®, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.
Two major studies out of MTSU tout job growth in allied health fields and the booming health-care industry in Nashville, Tenn. MTSU places a premium on partnerships and student participation in serving the public good.
The 30-day mortality rate of heart failure patients at Loyola University Hospital is 24 percent lower than the national average, according to the latest data from the federal government's Hospital Compare report card.
The University of Virginia School of Medicine is launching Memory Commons (www.memorycommons.org), an interactive, first-of-its-kind educational website for physicians and healthcare professionals that focuses specifically on Alzheimer’s Disease and dementia.
Mark R. Hartman, a Cornell University PhD candidate in Biological and Environmental Engineering will lead the team chosen to receive the $150,000 top honor in the 2010 CIMIT Prize in Primary Healthcare competition. His team’s project seeks to apply novel DNA-based “fluorescence nanobarcodes” as a platform technology for multiplexed rapid clinical diagnoses in primary care. Second place and $100,000 is awarded to another Cornell-based, student-led team. Third place and $50,000 goes to a team at the MIT Media Lab.
The University of Texas Health Science Center at Houston (UTHealth) announced that its Biotechnology Commercialization Center (BCC) has leased more than three-quarters of its available space to eight Texas-based startups in less than a year. The center’s focus is to assist biotech entrepreneurs and small companies with the translation of discoveries into innovative health solutions.
A computer security invention patented at NIST a decade ago is now poised to help safeguard patient privacy in hospitals.
In an effort to extend the length of a disability-free life for older adults, researchers from Rush University Medical Center are partnering with colleagues from across the U.S. and Australia in the largest international trial ever sponsored by the National Institute on Aging. The Aspirin in Reducing Events in the Elderly (ASPREE) study aims to assess whether aspirin can not only prolong life, but a life free of physical disability and/or dementia for healthy older people.
A national pilot study that will promote evidence-based evaluation and treatment standards for patients with resectable non small cell lung cancer (NSCLC) was launched yesterday by the Commission on Cancer (CoC) of the American College of Surgeons. The Commission on Cancer National Pilot Study for the ProvenCare® Lung Cancer Collaborative is based on the success of the Geisinger Health System’s ProvenCare model, which has significantly increased adherence to evidence-based standards, improved clinical outcomes, and engaged patients as participants in their own care when applied to acute care episodes associated with other disease sites.
The GBS/CIDP Foundation International has designated UTHealth as one of seven initial Centers of Excellence for the diagnosis and treatment of two inflammatory disorders.
Just one year after The University of Texas MD Anderson Cancer Center launched its secured, Web-based portal for personal health information, more than 28,000 patients (57 percent) who logged into myMDAnderson - a personalized, online connection to the center - have accessed their personal medical information, test results and records.
The American Medical Group Association (AMGA) today announced the addition of two new distribution methods to their Patient Satisfaction Benchmarking Survey: Interactive Voice Response (IVR) phone and web-enabled survey distribution methods.
Tangent Medical Technologies, Inc. geared to improving safety of IVs used for hospitalized patients, has reached a licensing agreement with the University of Michigan for its latest product.
An online service that positions itself as the “Craigslist of biospecimens” aims to eliminate one of the most costly bottlenecks in biomedical R&D - delays in obtaining specimens suitable for research.
Living wills and advance directives often don’t ensure that dying patients receive the kind of medical care they want — or don’t want — to receive. Now an effort being coordinated by the Center for Innovative Collaboration in Medicine & Law at the Florida State University College of Medicine hopes to improve communication and produce a clear set of medical orders for a dying patient’s care.
Proven Diagnostics, a clinical diagnostic laboratory located in Bethlehem, Pa., announced today that it has signed a contract with Highmark, the largest health insurer in Pennsylvania.
Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on developing diagnostic technologies to detect subtle differences in the cellular and molecular makeup of patient tissue samples.
As many as half of stroke survivors lose some of their ability to move their extremities. Now specialists in rehabilitation medicine at NewYork-Presbyterian Hospital/Columbia University Medical Center are pioneering the use of robotic devices to help them regain this function. Patients are currently being recruited for ongoing clinical research trials with the new devices.
Loyola University Health System (LUHS) has opened a clinic to treat the debilitating effects of chronic pelvic pain (CPP) in women. The clinic is located at the Loyola Outpatient Center at 2160 S. First Ave., in Maywood.
Mount Sinai School of Medicine has completed an exclusive option agreement with Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, for intellectual property related to RNAi applications in vaccine development.
The first commercially available treatment in the United States for a rare form of muscular dystrophy called late-onset Pompe disease was administered at the University of Florida Health Science Center on Wednesday.
Government data shows that more than 40 million U.S. workers do not have paid sick days. How many have gone to work with a contagious illness? How many send sick children to school? The results of a new survey conducted by the National Opinion Research Center that answers these and other pressing questions will be released at an audio news conference Monday.
Looking to harness the body’s own immune system to target prostate cancer that has spread to the bones and is unresponsive to standard treatment, investigators at New Jersey’s only NCI-Comprehensive Cancer Center have launched a clinical trial focusing on a combination of vaccine and radiation drug therapy. The goal is to see if disease progression will be further delayed by adding two different experimental injections to the standard treatment.
The new systems will change the way medications are ordered, labeled, stored, distributed and administered. UVA is working with four leading healthcare technology and service organizations to move from a centralized system, where a large number of medications are delivered on carts from the central pharmacy, to a decentralized medication distribution model.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right